These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 6693582)

  • 1. The relationship of plasma imipramine and N-desmethylimipramine to improvement in agoraphobia.
    Mavissakalian M; Perel JM; Michelson L
    J Clin Psychopharmacol; 1984 Feb; 4(1):36-40. PubMed ID: 6693582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relationship of plasma imipramine and N-desmethylimipramine to improvement in agoraphobia.
    Mavissakalian M; Perel J; Michelson L
    Psychopharmacol Bull; 1984; 20(1):123-5. PubMed ID: 6718637
    [No Abstract]   [Full Text] [Related]  

  • 3. The relationship of plasma imipramine and N-desmethylimipramine to response in panic disorder.
    Mavissakalian MR; Perel JM
    Psychopharmacol Bull; 1996; 32(1):143-7. PubMed ID: 8927664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma levels of tricyclic antidepressants in panic disorder.
    Sweeney DR; Gold MS; Pottash AL; Martin D
    Int J Psychiatry Med; 1983-1984; 13(2):93-6. PubMed ID: 6642878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Imipramine dose-response relationship in panic disorder with agoraphobia. Preliminary findings.
    Mavissakalian MR; Perel JM
    Arch Gen Psychiatry; 1989 Feb; 46(2):127-31. PubMed ID: 2643933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological treatment of agoraphobia: imipramine versus imipramine with programmed practice.
    Mavissakalian M; Michelson L; Dealy RS
    Br J Psychiatry; 1983 Oct; 143():348-55. PubMed ID: 6626853
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patterns of plasma imipramine-desipramine concentrations in patients receiving concomitant fluphenazine decanoate.
    Siris SG; Adan F; Lee A; Cooper TB; Mandeli J; Casey E
    J Clin Psychiatry; 1988 Feb; 49(2):64-5. PubMed ID: 3338977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Imipramine treatment of panic disorder with agoraphobia: dose ranging and plasma level-response relationships.
    Mavissakalian MR; Perel JM
    Am J Psychiatry; 1995 May; 152(5):673-82. PubMed ID: 7726306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current drug therapy for agoraphobia.
    Ravaris CL
    Am Fam Physician; 1981 Jan; 23(1):129-31. PubMed ID: 7457310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Imipramine in the treatment of agoraphobia: dose-response relationships.
    Mavissakalian M; Perel J
    Am J Psychiatry; 1985 Sep; 142(9):1032-6. PubMed ID: 3895987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Desipramine in agoraphobia with panic attacks: an open, fixed-dose study.
    Lydiard RB
    J Clin Psychopharmacol; 1987 Aug; 7(4):258-60. PubMed ID: 3624509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluvoxamine-induced alterations in plasma concentrations of imipramine and desipramine in depressed patients.
    Spina E; Pollicino AM; Avenoso A; Campo GM; Caputi AP
    Int J Clin Pharmacol Res; 1993; 13(3):167-71. PubMed ID: 8225700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Agoraphobia: relative and combined effectiveness of therapist-assisted in vivo exposure and imipramine.
    Mavissakalian M; Michelson L
    J Clin Psychiatry; 1986 Mar; 47(3):117-22. PubMed ID: 3512534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical response to clonidine and imipramine, and platelet alpha 2-adrenoreceptors in a case of agoraphobia with panic attacks.
    Zelnik TC; Garcia-Sevilla JA; Cameron OG; Smith CB
    Biol Psychiatry; 1982 Jun; 17(6):761-6. PubMed ID: 6285996
    [No Abstract]   [Full Text] [Related]  

  • 15. Tricyclic antidepressants and monoamine oxidase inhibitors in the treatment of agoraphobia.
    Pohl R; Berchou R; Rainey JM
    J Clin Psychopharmacol; 1982 Dec; 2(6):399-407. PubMed ID: 7174863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Depression in children: relationship between plasma imipramine levels and response.
    Preskorn SH; Weller EB; Weller RA
    J Clin Psychiatry; 1982 Nov; 43(11):450-3. PubMed ID: 7174621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imipramine and phobia [proceedings].
    Klein DF; Zitrin CM; Woerner MG
    Psychopharmacol Bull; 1977 Apr; 13(2):24-7. PubMed ID: 323907
    [No Abstract]   [Full Text] [Related]  

  • 18. Imipramine and desipramine plasma levels: relationship to dosage schedule and sampling time.
    Ziegler VE; Biggs JT; Rosen SH; Meyer DA; Preskorn SH
    J Clin Psychiatry; 1978 Aug; 39(8):660-3. PubMed ID: 681303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preliminary results of an open, fixed-dose study of desipramine in panic disorder.
    Lydiard RB
    Psychopharmacol Bull; 1987; 23(1):139-40. PubMed ID: 3602310
    [No Abstract]   [Full Text] [Related]  

  • 20. Imipramine and tinnitus.
    Tandon R; Grunhaus L; Greden JF
    J Clin Psychiatry; 1987 Mar; 48(3):109-11. PubMed ID: 3818550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.